Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 7702 (MIR7702) is a human microRNA belonging to the class of non-coding RNAs involved in post-transcriptional gene regulation. In colorectal cancer, miR-7702 is significantly downregulated in highly invasive cancer cell lines and functions as a **tumor suppressor** by inhibiting cell migration and invasion through direct inhibition of the TADA1 gene. This effect is species-specific and was confirmed in human but not mouse cells, highlighting MIR7702's relevance for human disease pathways. As with other microRNAs, the broader functions of MIR7702 are likely to include regulation of multiple transcripts, but published data on its other physiological or pathological roles remain limited. There are currently no known drugs targeting this microRNA, and it is not considered a conventional therapeutic target such as a receptor, enzyme, or transporter[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 7702 (MIR7702).